Uncategorized

By STAT

Nanotechnology in Medicine

By Tony Guzman

Good bacteria: The microbiome, its vast therapeutic potential, and the challenges ahead

Pharmalot By Ed Silverman

Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales

By Nicholas Florko

The operation formerly known as Warp Speed: Biden leans heavily on the flagship Trump-era initiative

Pharmalot By Ed Silverman

Insulin makers win a significant round in Minnesota lawsuit accusing them of racketeering

By Matthew Herper

GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients

By Damian Garde

Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval

By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Bracing for a pandemic winter, Biogen’s fortune at the FDA, and remembering a remarkable 12-year-old

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

By Erin Brodwin

How Pinterest beat back vaccine misinformation — and what Facebook could learn from its approach

Pharma By Adam Feuerstein

Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future

By Rebecca Robbins, Casey Ross and Erin Brodwin

STAT Health Tech: Elon Musk’s secretive brain implants startup & Verily’s move into health insurance

By Jonathan Chan

STAT China: Two more Hong Kong IPO filings, and Beijing’s latest drug price cuts

By Nicholas Florko

House Democrats are using the budget process to slam the Trump administration’s Covid-19 response  

Pharmalot By Ed Silverman

AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival

By Matthew Herper

Eli Lilly gets an edge against Pfizer in adjuvant breast cancer

Pharmalot By Ed Silverman

California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents

By Lev Facher

6 takeaways from the Senate’s surreal virtual hearing on the U.S. coronavirus response

By Shraddha Chakradhar

Last chance! Sign up for our STAT Plus event – “Gene therapy has arrived. What’s next?”

Biotech By Adam Feuerstein

Karyopharm to seek expanded use of multiple myeloma drug following positive clinical trial

By Damian Garde, Rebecca Robbins and Adam Feuerstein

Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome

Pharma By Jonathan Saltzman — Boston Globe

Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme

By STAT

[email protected] 2020

Biotech By Matthew Herper

Cleveland Clinic’s Nissen denies any communication with FDA about Amarin’s Vascepa

Politics By Lev Facher

Insurance, pharma figures spar over drug price legislation’s innovation impact